Home/ Stocks/ CLDX

Celldex Therapeutics, Inc

CLDX XNAS

$41.71 +0.15 (+0.36%) ▲ 15-min delayed

Open

$41.87

High

$42.92

Low

$41.29

Volume

808.9K

Market Cap

$3.26B

About Celldex Therapeutics, Inc

Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 198 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$15.0K	$-78,685,000	$-1.18
FY 2025	$1.54M	$-258,757,000	$-3.90
Q3 2025	$0	$-67,044,000	$-1.01
Q2 2025	$730.0K	$-56,600,000	$-0.85

Related Market News

No specific coverage for CLDX yet. Check out our latest market news or earnings calendar.

Get CLDX Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Celldex Therapeutics, Inc.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.